Skip to search formSkip to main contentSkip to account menu

modipafant

Known as: 3-Pyridinecarboxylic acid, 4-(2-chlorophenyl)-1,4-dihydro-6-methyl-2-(4-(2-methyl-1H-imidazo(4,5-c)pyridin-1-yl)phenyl)-5-((2-pyridinylamino)carbonyl)-, ethyl ester, 4-(2-chlorophenyl)-6-methyl-2-(4-(2-methylimidazo(4,5-c)pyrid-1-yl)phenyl)-5-(2-pyridinylcarbamoyl)-1,4-dihydropyridine-3-carboxylic acid ethyl ester 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (3)

DihydropyridinesImidazolesdihydropyridine

Narrower (1)

UK 74505

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Platelet‐activating factor drives eotaxin production in an allergic pleurisy in mice
The activation of eosinophils via G‐protein‐coupled seven transmembran receptors play a necessary role in the recruitment of… 
2002
2002
Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules.
1. Protein synthesis dependency and the role of endogenously generated platelet activating factor (PAF) and leukotriene B(4) (LTB… 
1996
1996
Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
1. The pharmacokinetics and disposition of modipafant, a dihydropyridine PAF antagonist, were studied in rat and dog following… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)